Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Antiandrogen therapy helps treat genetic hair loss.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

New understanding and treatments for hair loss are improving, but more research is needed.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Iron deficiency might contribute to hair loss in women.

The combination therapy was effective and well-tolerated, especially in young patients.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Wnt10b overexpression can regenerate hair follicles, possibly helping treat hair loss and alopecia.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Finasteride can cause sexual problems and depression in young men.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Trichotillomania is often misdiagnosed as alopecia areata and can be treated effectively with N-acetylcysteine and psychotropic drugs.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

New treatments for hair loss and excessive hair growth show promise with few side effects and advancements in laser technology.